Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Operating Margin %: 44.39% (As of Mar. 2026) — 112% Above Median


SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
76 GF Score
Price ¥41.46
GF Value ¥66.54
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Operating Margin %?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 -6.83% 76 Operating Margin % is 44.39% as of Mar. 2026, which is 112% above its 10-year median of 20.95. GuruFocus rates SHSE:688336 with a GF Score™ of 76/100 and a GF Value™ of ¥66.54 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 944 Biotechnology companies, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks better than 99.05% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Income for the three months ended in Mar. 2026 was ¥191 Mil. Sunshine Guojian Pharmaceutical (Shanghai) Co's Revenue for the three months ended in Mar. 2026 was ¥431 Mil. Therefore, Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % for the quarter that ended in Mar. 2026 was 44.39%.

The historical rank and industry rank for Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % or its related term are showing as below:

SHSE:688336' s Operating Margin % Range Over the Past 10 Years
Min: -33.26   Med: 20.95   Max: 75.33
Current: 75.33


SHSE:688336's Operating Margin % is ranked better than
99.05% of 944 companies
in the Biotechnology industry
Industry Median: -86.83 vs SHSE:688336: 75.33

Sunshine Guojian Pharmaceutical (Shanghai) Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Income for the three months ended in Mar. 2026 was ¥191 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3,253 Mil.


Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Sunshine Guojian Pharmaceutical (Shanghai) Co Operating Margin % Related Terms


Sunshine Guojian Pharmaceutical (Shanghai) Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co Operating Margin % Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.89 0.61 20.90 21.00 75.19

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.65 14.09 46.86 90.60 44.39

SHSE:688336 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Guojian Pharmaceutical (Shanghai) Co Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % falls into.


SHSE:688336
76GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=3157.398 / 4199.118
=75.19 %

Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=191.425 / 431.234
=44.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 44.39% mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Operating Margin % of 44.39% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. This is 112% above median its historical median of 20.95. According to the industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #9 out of 944 companies in the Biotechnology industry, placing it in the top 1%.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Operating Margin % of 44.39% is 112% above median its 10-year median of 20.95. Based on the distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #9 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #9 out of 944 companies for Operating Margin %. This places Sunshine Guojian Pharmaceutical (Shanghai) Co in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Operating Margin % is 44.39%, which is 112% above median its own 10-year median of 20.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Possible Value Trap. The stock's GF Value™ is ¥66.54, compared to a current price of ¥41.46 — trading 37.7% below its estimated fair value. The current Operating Margin % is 44.39%, which is 112% above median its 10-year median of 20.95. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Operating Margin % is 44.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥41.46 is trading 37.7% below its estimated GF Value™ of ¥66.54. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Possible Value Trap.

Key valuation signals for SHSE:688336:

  • Operating Margin %: 44.39% (112% above median its 10-year median of 20.95)
  • GF Value™: ¥66.54 vs. price of ¥41.46 (37.7% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
76GF Score

Get the complete analysis for SHSE:688336

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥41.46
Price
¥66.54
GF Value